BioInformant is the global leader in stem cell industry data. As a specialty research company, we use technology to track and identify profitable opportunities within the stem cell sector and provide this data to clients pursuing aggressive growth. We serve two primary types of clients: research supply companies and cord blood banks.
We are the only market intelligence company that has specifically served the stem cell market since it emerged. Our singular focus on this industry and our historical knowledge of it makes us uniquely positioned to be your source of targeted, strategic information.
We began tracking the stem cell industry in 2004 when only two types of stem cells existed, adult stem cells and embryonic stem cells. Today, researchers debate the number of stem cells in existence, as the number depends on whether stem cells are characterized functionally (e.g. neural stem cells, mesenchymal stem cells, induced pluripotent stem cells) or characterized by source tissue (e.g cord blood stem cells, dental pulp stem cells, amniotic stem cells, etc.).
What is clear is that dozens of stem cell types now exist, all representing unique opportunities for your company.
This means we understand the current and future product trends more intimately than any other company. When we say we’re a global leader in stem cell industry data, it is because it is our sole focus.
Put simply, we stay ahead of our competition, so you can stay ahead of yours.
Our team of technology specialists, business analysts, and scientific experts produce data that enables decision-makers within stem cell companies to better understand their markets, competitors, and customers. Our clients succeed at developing high-demand products that bring customers to them instead of the competition.
To date, we have served nearly all of the world's leading research supply companies, including:
Because cord blood is richly populated with stem cells, we have also have been tracking the cord blood banking industry since 2006 and are the leading supplier of cord blood industry data worldwide.
To date, we have also served nearly all of the world's leading cord blood banks, including:
Cells For Life Cord Blood Institute
In summary, BioInformant Worldwide, LLC, is your global leader in stem cell industry data, including cord blood industry data. Serving Fortune 500 leaders that include Pfizer, Goldman Sachs, and Thermo Fisher Scientific, and featured on prominent news outlets including the Wall Street Journal and Yahoo Finance, BioInformant is a premium market research provider within the industry.
Copyright © 2014 BioInformant Worldwide, L.L.C. All rights reserved.
|Home | Company | Our Clients | Contact Us|